Campylobacter fetus as cause of prosthetic valve endocarditis

Texas Heart Institute Journal

Volumn 38, Issue 5, 2011, Pages 584-587

  Haruyama, Akiko ^a   Toyoda, Shigeru ^a   Kikuchi, Migaku ^a   Arikawa, Takuo ^a   Inami, Shu ^a   Otani, Naoyuki ^a   Amano, Hirohisa ^a   Matsuda, Ryuko ^a   Inoue, Teruo ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti bacterial agents therapeutic use; Aortic valve; Bacterial drug therapy etiology; Campylobacter fetus; Campylobacter infections complications epidemiology; Endocarditis; Heart valve prosthesis adverse effects; Vibrio drug effects

Indexed keywords

AMOXICILLIN; AMPICILLIN; C REACTIVE PROTEIN; CEFDINIR; CILASTATIN PLUS IMIPENEM; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; MINOCYCLINE; VANCOMYCIN;

AGED; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; BLOOD PRESSURE; BODY TEMPERATURE; CAMPYLOBACTER FETUS; CASE REPORT; DRUG SENSITIVITY; DRUG SUBSTITUTION; ELECTROCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; FIRST DEGREE ATRIOVENTRICULAR BLOCK; HEART RATE; HEART VALVE PROSTHESIS; HUMAN; IN VITRO STUDY; LABORATORY TEST; LEUKOCYTE COUNT; NEUTROPHIL; PHYSICAL EXAMINATION; PROSTHETIC VALVE ENDOCARDITIS; SORE THROAT; THORAX RADIOGRAPHY; TOOTH PAIN; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; ANTI-BACTERIAL AGENTS; AORTIC VALVE; BIOPROSTHESIS; CAMPYLOBACTER FETUS; CAMPYLOBACTER INFECTIONS; DENTAL CARIES; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ENDOCARDITIS, BACTERIAL; FEMALE; FOOD CONTAMINATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MEAT; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; TREATMENT OUTCOME;

EID: 83455179294     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Morrison VA, Lloyd BK, Chia JK, Tuazon CU. Cardiovascular and bacteremic manifestations of Campylobacter fetus infection: case report and review. Rev Infect Dis 1990;12(3): 387-92.
2. Gazaigne L, Legrand P, Renaud B, Bourra B, Taillandier E, Brun-Buisson C, Lesprit P. Campylobacter fetus bloodstream infection: risk factors and clinical features. Eur J Clin Microbiol Infect Dis 2008;27(3):185-9.
3. Caramelli B, Mansur AJ, Grinberg M, Mendes CM, Pileggi F. Campylobacter fetus endocarditis on a prosthetic heart valve. South Med J 1988;81(6):802-3.
4. Farrugia DC, Eykyn SJ, Smyth EG. Campylobacter fetus endocarditis: two case reports and review. Clin Infect Dis 1994; 18(3):443-6.
5. Peetermans WE, De Man F, Moerman P, van de Werf F. Fatal prosthetic valve endocarditis due to Campylobacter fetus. J Infect 2000;41(2):180-2.
6. Bayer AS, Ward JI, Ginzton LE, Shapiro SM. Evaluation of new clinical criteria for the diagnosis of infective endocarditis. Am J Med 1994;96(3):211-9.
7. Wagenaar JA, van Bergen MA, Newell DG, Grogono-Thomas R, Duim B. Comparative study using amplified fragment length polymorphism fingerprinting, PCR genotyping, and phenotyping to differentiate Campylobacter fetus strains isolated from animals. J Clin Microbiol 2001;39(6):2283-6.
8. Butzler JP, Dekeyser P, Lafontaine T. Susceptibility of related vibrios and Vibrio fetus to twelve antibiotics. Antimicrob Agents Chemother 1974;5(1):86-9.
9. Ward BQ. The apparent involvement of Vibrio fetus in an infection of man. J Bacteriol 1948;55(1):113-4.
10. Miki K, Maekura R, Hiraga T, Hirotani A, Hashimoto H, Kitada S, et al. Infective tricuspid valve endocarditis with pulmonary emboli caused by Campylobacter fetus after tooth extraction. Intern Med 2005;44(10):1055-9.